Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents

about

Recent advances using zebrafish animal models for muscle disease drug discovery

P2860

Q28551915-FFA6455D-EEBA-478B-AD6E-231BBC24323E

P2860

Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents

Item

http://www.wikidata.org/entity/Q36925191

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Novel compounds for the treatm ...... y: emerging therapeutic agents

@en

type

Item

label

Novel compounds for the treatm ...... y: emerging therapeutic agents

@en

prefLabel

Novel compounds for the treatm ...... y: emerging therapeutic agents

@en

P1476

Novel compounds for the treatm ...... y: emerging therapeutic agents

@en

P2093

Steve D Wilton

http://www.w3.org/2001/XMLSchema#string

P2860

Glucocorticoid corticosteroids for Duchenne muscular dystrophy

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy

Automated drug screening with contractile muscle tissue engineered from dystrophic myoblasts

Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study

Delivery of recombinant follistatin lessens disease severity in a mouse model of spinal muscular atrophy.

Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient mdx mouse: cardiac protection and improved exercise performance

Gene-specific countermeasures against Ebola virus based on antisense phosphorodiamidate morpholino oligomers.

Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy

Antisense oligonucleotide induced exon skipping and the dystrophin gene transcript: cocktails and chemistries

Molecular basis for the high-affinity binding and stabilization of firefly luciferase by PTC124

P304

29-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TACG.S8762

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sue Fletcher

P577

2011-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23776365

http://www.w3.org/2001/XMLSchema#string

P932

3681176

http://www.w3.org/2001/XMLSchema#string

Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents

about

P2860

P2860

Novel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agents

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932